Synthetic Neoglycoconjugates of Hepta‐ and Nonamannoside Ligands for Eliciting Oligomannose‐Specific HIV‐1‐Neutralizing Antibodies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Synthetic Neoglycoconjugates of Hepta‐ and Nonamannoside Ligands for Eliciting Oligomannose‐Specific HIV‐1‐Neutralizing Antibodies ; day:11 ; month:02 ; year:2022 ; extent:1
ChemBioChem ; (11.02.2022) (gesamt 1)
- Urheber
-
Cattin, Matteo
Bruxelle, Jean‐François
Ng, Kurtis
Blaukopf, Markus
Pantophlet, Ralph
Kosma, Paul
- DOI
-
10.1002/cbic.202200061
- URN
-
urn:nbn:de:101:1-2022021114274189023353
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cattin, Matteo
- Bruxelle, Jean‐François
- Ng, Kurtis
- Blaukopf, Markus
- Pantophlet, Ralph
- Kosma, Paul
Ähnliche Objekte (12)
Eliciting neutralizing antibodies with gp120 outer domain
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Retracted: Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
Retraction Note: eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
Eliciting CD4-mimicking broadly neutralizing antibodies: new avenues towards the rational design of an HIV vaccine
Broadly Neutralizing Antibodies for HIV Eradication
Non-neutralizing antibodies and vaccine-induced protection
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Beyond glycan barriers: non-cognate ligands and protein mimicry approaches to elicit broadly neutralizing antibodies for HIV-1
The expanding array of HIV broadly neutralizing antibodies
Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies
Rapid detection of anti-Vaccinia virus neutralizing antibodies
Eliciting neutralizing antibodies with gp120 outer domain
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Retracted: Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
Retraction Note: eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
Eliciting CD4-mimicking broadly neutralizing antibodies: new avenues towards the rational design of an HIV vaccine
Broadly Neutralizing Antibodies for HIV Eradication
Non-neutralizing antibodies and vaccine-induced protection
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Beyond glycan barriers: non-cognate ligands and protein mimicry approaches to elicit broadly neutralizing antibodies for HIV-1
The expanding array of HIV broadly neutralizing antibodies
Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies
Rapid detection of anti-Vaccinia virus neutralizing antibodies
Eliciting neutralizing antibodies with gp120 outer domain
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Retracted: Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
Retraction Note: eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
Eliciting CD4-mimicking broadly neutralizing antibodies: new avenues towards the rational design of an HIV vaccine
Broadly Neutralizing Antibodies for HIV Eradication
Non-neutralizing antibodies and vaccine-induced protection
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Beyond glycan barriers: non-cognate ligands and protein mimicry approaches to elicit broadly neutralizing antibodies for HIV-1
The expanding array of HIV broadly neutralizing antibodies
Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies